Evaluation the effect of co-enzyme Q10 in patients with thalassemia major

Phase 1

• Conditions: thalassemia major.; Beta thalassemia; D56.1

• Registration Number: IRCT20221211056777N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

patient with thalassemia major

Exclusion Criteria

Non-cooperation of the patient
The presence of side effects
People who suffer from infection and inflammation.
Death of the patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The level of superoxide dismutase, catalase and peroxidase enzymes and ferritin serum level. ESR, CRP. Timepoint: Before the intervention and eight weeks after the intervention. Method of measurement: ELISA test kit.